雾化吸入布地奈德混悬液在妊娠合并支气管哮喘轻中度急性发作中的临床效果分析

目的:探究妊娠合并支气管哮喘轻中度急性发作患者通过布地奈德混悬液雾化吸入治疗后取得的临床成效。方法:选取我院2011-2016入院的妊娠合并支气管哮喘轻中度急性发作患者40例,随机分为观察组和对照组各20人。对照组治疗方法为常规治疗,观察组为布地奈德混悬液雾化吸入治疗。针对治疗有效率、不良反应发生情况,对两组进行分析。结果:在治疗效果方面,观察组治疗总有效率(95%)比对照组(75%)高(P<0.05);针对不良反应发生情况,观察组发生率(10%)与对照组(5%)相比无明显差异(P>0.05)。结论:妊娠合并支气管哮喘轻中度急性发作患者通过布地奈德混悬液雾化吸入治疗后,能够有效提高治疗效果,不良反应发生率较低,应推广应用。

Objective: To investigate the clinical efficacy of aerosol inhalation of Budesonide suspension in patients with mild to moderate acute exacerbation of pregnancy complicated with bronchial asthma. Methods: Forty patients with mild to moderate acute exacerbation of pregnancy and bronchial asthma admitted in our hospital from 2011 to 2015 were randomly divided into observation group and control group. The control group was treated with routine therapy, and the observation group was treated with budesonide suspension inhalation. For the treatment of effective, adverse reactions, the two groups were analyzed. Results: In the treatment effect, the total effective rate(95%) of the observation group was higher than that of the control group(75%)(P <0.05); For the adverse reaction, the incidence of observation group(10%) and control group %). There was no significant difference between the two groups(P> 0.05). Conclusion: Inhalation of budesonide suspension in patients with mild to moderate acute exacerbation of bronchial asthma in pregnancy can effectively improve the therapeutic effect. The incidence of adverse reactions is low, and should be popularized.